% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 34

Loading Chart...

5 inventors (with patents filed for the assignee):

Lin Zhi (4 out of 127 patents)

Zucai Suo (4 out of 4 patents)

David J Taggart (2 out of 2 patents)

4. Sheng Cao (1 out of 3 patents)

5. Vinod P Vyavhare (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12110311 - Cyclic deoxyribonucleotide compounds (2024-10-08),

2. 12110308 - Phosphor(n)amidatacetal and phosph(on)atalcetal compounds (2024-10-08),

3. 11427550 - 5-fluorouracil compounds (2022-08-30),

4. 10435429 - 5-fluorouridine monophosphate cyclic triester compounds (2019-10-08),

5. 10059733 - Gemcitabine analogs (2018-08-28),

6. 10000521 - Substituted gemcitabine bicyclic amide analogs and treatment methods using same (2018-06-19),

7. 9744186 - Substituted gemcitabine aryl amide analogs (2017-08-29),

8. 9447137 - Substituted gemcitabine aryl amide analogs (2016-09-20),

Company Overview

Nucorion Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative medicines for unmet medical needs. With a focus on research and development, we strive to bring new treatment options to patients worldwide. Our commitment to excellence and scientific integrity drives us to pursue cutting-edge solutions in the field of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#636 in San Diego, CA

#8,543 in California

#35,941 in US

San Diego, CA, United States of America

Nucorion Pharmaceuticals, Inc.

Forward Citations = 34

5 inventors:

Lin Zhi (4 out of 127 patents)

Zucai Suo (4 out of 4 patents)

David J Taggart (2 out of 2 patents)

4. Sheng Cao (1 out of 3 patents)

5. Vinod P Vyavhare (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nucorion Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/nucorion-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]